International Flavors & Fragrances is the largest specialty ingredients producer globally... Show more
International Flavors & Fragrances is navigating a major transformation as it prepares to separate its Food Ingredients business, positioning the company to focus on its higher-growth Taste, Scent, and Health & Biosciences segments. This third-quarter report offered investors a key read on whether those core businesses can sustain momentum while the divestiture process unfolds. IFF has also been working to improve profitability and cash flow, making adjusted EBITDA and free cash flow closely watched metrics. With a completed $500 million accelerated share repurchase program and a Food Ingredients sale targeted to close by mid-2027, the quarter provided an important checkpoint on execution across both the operating and portfolio-simplification fronts.
IFF reported third-quarter 2026 revenue of $1.94 billion, a roughly 4% increase from $1.87 billion a year earlier and above the consensus estimate of about $1.91 billion. Organic revenue grew 5% year over year on a comparable, currency-neutral basis, led by mid-single-digit growth in the Scent and Taste segments and low-single-digit growth in Health & Biosciences.
Adjusted earnings per share came in at $0.83, exceeding the $0.81 consensus estimate. Adjusted operating EBITDA totaled $403 million, up 6% on a comparable currency-neutral basis and ahead of the approximately $391.8 million consensus. On a GAAP (Generally Accepted Accounting Principles) basis, results were weighed down by items including goodwill impairment, divestiture-related costs, and losses tied to assets held for sale, reflecting the ongoing portfolio restructuring.
For the full year, IFF raised its revenue guidance to a range of $7.5 billion to $7.6 billion, from $7.4 billion to $7.6 billion previously, and lifted its adjusted operating EBITDA outlook to $1.55 billion to $1.60 billion. However, the new revenue midpoint of $7.55 billion sat slightly below the roughly $7.589 billion consensus, which investors viewed as a modest negative.
Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like IFF and its industry peers, it offers a streamlined way to spot developing setups and trends.
IFF shares declined about 3% in after-hours trading following the release, even though the company beat on revenue, adjusted EPS, and adjusted EBITDA. The pullback reflected investor focus on the full-year revenue guidance, whose midpoint landed slightly below consensus, as well as the company's comment that fourth-quarter profitability is expected to be softer, particularly in Health & Biosciences, due to higher costs and planned reinvestments. The reaction suggests the market had priced in strong execution and was looking for a clearer, more positive trajectory into 2027. Ongoing progress on the Food Ingredients separation was viewed favorably, but near-term margin pressures and a cautious guidance tone weighed on sentiment.
Looking ahead, investors will be watching how IFF balances near-term profitability pressures against its longer-term transformation. The company has flagged that fourth-quarter results, especially in Health & Biosciences, may be softer as it absorbs higher costs and reinvests to strengthen the business. This makes the pace and durability of margin recovery in that segment a central focus heading into the next report.
The Food Ingredients divestiture remains the biggest structural catalyst. Management said the separation is progressing well and remains on track to close by the end of the second quarter of 2027. The completion of the transaction and the eventual deployment of proceeds will shape IFF's balance sheet and its ability to return capital to shareholders.
Finally, investors should monitor demand trends across the Scent and Taste businesses, currency and input-cost dynamics, and the company's free cash flow conversion, which management has tied to compensation. Together, these factors will help determine whether IFF can sustain its recent momentum while completing one of the most significant portfolio changes in its history.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of flavor and fragrance products
Industry ChemicalsSpecialty